Peptide Encyclopedia / MGF
EncyclopediaMGF is a splice variant of IGF-1 (IGF-1Ec) that muscle expresses after loading or damage, and its E-peptide region is thought to activate satellite cells for repair and growth. The FDA has not approved it, WADA prohibits it, and evidence rests on animal and cell studies. Educational only, not medical advice.
| Category | Growth Hormone |
| Regulatory status | Not FDA-approved. |
A splice variant of IGF-1 (IGF-1Ec) expressed locally in mechanically loaded or damaged muscle; its E-peptide region is thought to activate quiescent muscle satellite (stem) cells and promote their proliferation, contributing to muscle repair and hypertrophy.
The unmodified synthetic E-peptide is degraded very rapidly in serum (reported on the order of minutes). It is a peptide. Human pharmacokinetic data are limited.
Not FDA-approved. Sold as a research chemical / for laboratory use only. As an IGF-1-related growth factor it falls under substances prohibited by WADA.
Limited safety data; theoretical concerns mirror IGF-1 (growth signaling, potential effect on tumor promotion). Purity and contamination of research-grade material are practical concerns.
Mechanistic/animal and cell-culture evidence; no robust human clinical trials supporting performance or anti-aging use.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. MGF may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.